tion of " in groups ". Since by definition we are all out of most "in groups ", keeping up to date is often impossible and one can easily overlook quite important developments. In oncology, for example, relevant articles appear in specialist journals devoted to radiobiology, pharmacology, virology, immunology and genetics while clinical journals carry many articles of oncological interest. Abstracting services provide a partial solution to the problem of getting up to date, but paradoxically the appearance of new specialist journals covering contiguous areas of classic studies may be of great value. Such is perhaps the case with immunogenetics, a subject which involves antigenic polymorphisms and has recently come of age in studies of the genetic control of immune responsiveness and of antibody structure. There is much of interest in immunology and in genetics to cancer studies, particularly the antigenicity of tumours and the ability of the host to respond to them. The immunological and genetic interactions between oncogenic viruses, host genotypes, somatic mutations and environmental mutagens are, with cell kinetics and the genetic control of differentiation, areas of great interest in fundamental oncological research.
In his editorial introduction to Volume I, 
